The Journal of Infectious Diseases · 2001 · 359 citations · 13 references
MedicineInfectious DiseasesPharmacologyClinical PharmacologyPediatric GastroenterologyPediatric Infectious DiseasesDiarrhea ManagementGastrointestinal PharmacologyInfectious DiarrheaIntestinal Protozoan InfectionsPediatric Diarrheal DisordersPediatric Intestinal DisordersAcute Diarrhea ManagementAdult Acute Diarrhea TreatmentCryptosporidiosis TreatmentPediatric Diarrhea ManagementPediatric Diarrhea TreatmentPlacebo ComparatorsPlacebo-controlled Efficacy Assessment
A prospective randomized, double-blind, placebo-controlled study was conducted in 50 adults and 50 children from the Nile delta of Egypt, to evaluate the efficacy of nitazoxanide in treating diarrhea caused by Cryptosporidium parvum. Nitazoxanide was administered in 500-mg doses twice daily for 3 days in adults and adolescents, in 200-mg doses twice daily for 3 days in children aged 4-11 years, and in 100-mg doses twice daily for 3 days in children aged 1-3 years. At 7 days after initiation of therapy, diarrhea had resolved in 39 (80%) of the 49 patients in the nitazoxanide treatment group, compared with 20 (41%) of 49 in the placebo group (P<.0001). Diarrhea was resolved in most patients receiving nitazoxanide within 3 or 4 days of treatment initiation. Nitazoxanide treatment reduced the duration of both diarrhea (P<.0001) and oocyst shedding (P<.0001).
13
Principles and Practice of Infectious Diseases.
Annals of Internal Medicine · 1991 · 12.1K citations
Practice Guidelines for the Management of Infectious Diarrhea
Richard L. Guerrant, Thomas Van Gilder, Nathan M. Thielman et al. · Clinical Infectious Diseases · 2001 · 1.1K citations · Full text
D I Guerrant, Sean R. Moore, Aldo Â. M. Lima et al. · American Journal of Tropical Medicine and Hygiene · 1999 · 468 citations
Medicine, Child Health, Pediatrics +17
Jean‐François Rossignol, H Hidalgo, M. Feregrino et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene · 1998 · 175 citations